Back to Drug index

Back to Narcotic Analgesics

Brand Name: Meperitab
Name: Meperidine

pivca.jpg (220x140 -- 10891 bytes)
 

Percutaneous in-situ coronary venous arterialization is a new less invasive alternative to CABG.

 
 

 
prntfrnd.gif (30x26 -- 1309 bytes)printer friendly version
 
   
 
 
 
  Related
 
 

Transesophageal echo: uses, techniques and complications
Cardiology Discussion board

 
   
 
     

Pregnancy Category B

Drug classes
Narcotic agonist analgesic

Mechanism of action of Meperitab
Acts as agonist at specific opioid receptors in the CNS to produce analgesia, euphoria, sedation; the receptors mediating these effects are thought to be the same as those mediating the effects of endogenous opioids (enkephalins, endorphins).

Indications of Meperitab

  1. Relief of moderate to severe pain (oral, parenteral)
  2. Preoperative medication, support of anesthesia, and obstetric analgesia
    (parenteral)

Contraindications of Meperitab

  1. Presence of hypersensitivity to narcotics,
  2. Diarrhea caused by poisoning (before toxins are eliminated)
  3. Bronchial asthma, COPD, cor pulmonale, respiratory depression, anoxia
  4. Kyphoscoliosis
  5. Acute alcoholism
  6. Increased intracranial pressure
  7. Pregnancy

Use caution in the presence of acute abdominal conditions, cardiovascular disease, supraventricular tachycardias, myxedema, convulsive disorders, delirium tremens, cerebral arteriosclerosis, ulcerative colitis, fever, Addison's disease, prostatic hypertrophy, urethral stricture, recent GI or GU surgery, toxic psychosis, labor or delivery (administration of narcotics, including meperidine, to the mother can cause respiratory depression of neonate; premature infants are especially at risk), renal or hepatic dysfunction.

Adverse effects of Meperitab

May produce less intense smooth muscle spasm, less constipation, less cough reflex suppression than equianalgesic doses of morphine.

  • CNS: Lightheadedness, dizziness, sedation, euphoria, dysphoria, delirium, insomnia, agitation, anxiety, fear, hallucinations, disorientation, drowsiness, lethargy, impaired mental and physical performance, coma, mood changes, weakness, headache, tremor, convulsions, miosis, visual disturbances, suppression of cough reflex
  • GI: Nausea, vomiting, dry mouth, anorexia, constipation, biliary tract spasm, increased colonic motility in patients with chronic ulcerative colitis
  • CV: Facial flushing, peripheral circulatory collapse, tachycardia, bradycardia, arrhythmia, palpitations, chest wall rigidity, hypertension, hypotension, orthostatic hypotension, syncope
  • GU: Ureteral spasm, spasm of vesical sphincters, urinary retention or hesitancy, oliguria, antidiuretic effect, reduced libido or potency
  • Dermatologic: Pruritus, urticaria, laryngospasm, bronchospasm, edema
    Local: tissue irritation and induration (SC injection)
  • Major hazards: Respiratory depression, apnea, circulatory depression, respiratory arrest, shock, cardiac arrest
  • Other: Sweating, physical tolerance and dependence, psychological dependence

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us